Neogen/$NEOG

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Neogen

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

Ticker

$NEOG
Sector
Primary listing

Employees

2,974

Neogen Metrics

BasicAdvanced
$1.3B
-
-$5.03
1.79
-

What the Analysts think about Neogen

Analyst ratings (Buy, Hold, Sell) for Neogen stock.

Bulls say / Bears say

Core Food Safety revenue grew in the low single digits in Q4 FY25, showing resilience despite a sluggish market. (Nasdaq)
Management introduced a multi-faceted improvement plan centered on Growth Acceleration, Portfolio & Leverage, and Governance & Compliance, showing proactive steps to improve long-term profitability. (Investing.com)
As of May 31, 2025, Neogen had $129 million in cash and $150 million in unused borrowing capacity, ensuring liquidity for strategic actions and debt repayment. (Nasdaq)
Q4 FY25 revenue fell 4.8% year-over-year to $225.5 million, highlighting continued weak demand in its main markets. (Investing.com)
Adjusted EBITDA decreased to $40.6 million from $53.0 million, with margins dropping from 22.4% to 18.0% due to production inefficiencies and tariff pressures. (Investing.com)
The company posted a net loss of $612.2 million in Q4 FY25, primarily due to a non-cash goodwill impairment charge, which hit the balance sheet hard. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.

Neogen Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Neogen Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NEOG

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs